Skip to main content
. 2020 Dec 17;13(2):e12640. doi: 10.15252/emmm.202012640

Figure 8. EC8042 induces mesenchymal differentiation in rhabdoid tumor xenografts.

Figure 8

Immunohistochemistry analysis of H&E stains from G401 xenograft tumors on 1, 3, and 7 days after treatment with vehicle or 3‐day EC8042 infusion. EC8042‐treated xenograft tumors exhibit evidence of mesenchymal differentiation compared to vehicle. micro‐CT analysis of xenograft tumors on 7 days after treatment exhibit enhanced calcification compared to vehicle. IHC scale bar (lower left): 100 μm.